Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Personalizing treatment in multiple myeloma: approaching patients with t(4;14) and t(11;14)

In this video, Gareth Morgan, MD, PhD, FRCP, FRCPath, NYU Langone Health, New York City, NY, briefly discusses potential therapeutic approaches for patients with t(4;14) and t(11;14) multiple myeloma, and further comments on the value of personalizing treatment in this disease. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.